Supplier Type
- contract manufacturer
- custom synthesis
- Trader
- Manufacturer
- Reagent
Supplier Region
- Maharashtra(9)
- New Delhi(2)
- Hyderabad(22)
- Andhra Pradesh(3)
- Gujarat(11)
- Tamil Nadu(1)
- Mumbai(19)
- Ahmedabad(2)
- Delhi(4)
- Bangalore(2)
- Karnataka(3)
- Uttar Pradesh(1)
- Telangana(2)
- Pune(1)
- Vadodara(1)
Purity
- Empagliflozin intermediate, Dapagliflozin Impurity
- Clear
- 99.90%
- 99.9%
- 99.89%
- 99.86%
- 99.80%
- 99.71%
- 99.20%
- 99.04%
- 99.0% Min
- 99% HPLC
- 99%
- >99%
- 99
- 98+
- 98.93%
- 98.80%
- 98.62%
- 98.00%
- 98%
- >98%
- 97-99%
- 97.98%
- 97.60%
- 97.00%
- 97.0%
- >97%
- 97%
- 95.93%
- 95.69%
- 95.60%
- 95.00%
- 95.0%
- 95%
- 90 % Above
- 4%/8% & 1.6M
- 0.5M
Package
- 25mg
- 100mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 500ml
- 500g
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 50Kg
- 100kg
- 500kg
- 1and gm
- 1MT
-
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-
162012-67-1
-
2-Bromo-5-fluoroisonicotinic acid
885588-12-5
-
2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene
1030825-20-7
-
4-FLUORO-N-ISOPROPYLANILINE
70441-63-3
-
2-Chloro-3-fluoropyridine
17282-04-1
-
Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, 2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-N-(phenylmethyl)-, (3S,11aR)-
2883234-41-9
-
Favipiravir
259793-96-9
-
4-Fluoro-3-(trifluoromethyl)phenol
61721-07-1
-
4-(4-FLUORO-3-METHYLPHENYL)-4-OXOBUTYRIC ACID
349-22-4
-
2-Fluoro-4-(methylsulfonyl)aniline
832755-13-2
1-Cyclopropyl-3-(2-fluoro-4-iodo-phenyl)-urea 871700-18-4
custom synthesis
Contract Research
Karnataka
Phone: 91-8133254502
Whatsapp: 91-8133254502
Web: www.neugenlabs.com
Email: info@neugenlabs.com
Product catalog:
98
5-Fluoro-5'-deoxyuridine 3094-09-5
Trader
1Y
Karnataka
Phone: +91-9177992371
Tel: +91-9989216127
Whatsapp: +91-9177992371
Web: www.sparkvee.com
Product catalog:
26
5-Bromo, 2-Chloro 1-(4-Methoxydiphenyl)Methane, Technical Grade, 25 kg 333361-51-6
Reagent
Note:Purity: Empagliflozin intermediate, Dapagliflozin Impurity | Package: 1Kg;INR









